Form 4 for EVER EverQuote, Inc.
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0000950170-25-024894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-02-21 | 2025-02-19+ | EVER | Brainard David | CTO | S - Sale+OE | $21.58 | -7,521 | 156.8K | -5% | -$162.3K |
| DMT | 2025-02-21 | 2025-02-20 | EVER | Brainard David | CTO | M - OptEx | $7.35 | +6,609 | 163.4K | +4% | +$48.6K |
| DMT | 2025-02-21 | 2025-02-20 | EVER | Brainard David | CTO | M - OptEx | $0.00 | -6,609 | 6,343 | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-19 | S | D | 912 | $22.21 | 156,783 | D | — | — | (F1) The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 15, 2025. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The sale does not represent a discretionary trade by the reporting person. |
| 2 | Common | Class A Common Stock | 2025-02-20 | M | A | 1,562 | $9.41 | 158,345 | D | — | — | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. |
| 3 | Common | Class A Common Stock | 2025-02-20 | M | A | 1,250 | $5.54 | 159,595 | D | — | — | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. |
| 4 | Common | Class A Common Stock | 2025-02-20 | M | A | 3,797 | $7.10 | 163,392 | D | — | — | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. |
| 5 | Common | Class A Common Stock | 2025-02-20 | S | D | 6,609 | $21.49 | 156,783 | D | — | — | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $21.90, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| 6 | Derivative | Stock Option (right to buy) | 2025-02-20 | M | D | 625 | $0.00 | 6,250 | D | $7.10 · — to 2033-07-23 | 625 Class A Common Stock | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F6) This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a four-year period from the vesting start date. |
| 7 | Derivative | Stock Option (right to buy) | 2025-02-20 | M | D | 1,250 | $0.00 | 8,750 | D | $5.54 · — to 2032-10-23 | 1,250 Class A Common Stock | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F5) This option was granted on October 24, 2022. The vesting start date for the shares underlying the option is November 20, 2024 and vesting occurs quarterly over a two-year period from the vesting start date. |
| 8 | Derivative | Stock Option (right to buy) | 2025-02-20 | M | D | 1,562 | $0.00 | 7,813 | D | $9.41 · — to 2032-06-27 | 1,562 Class A Common Stock | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F4) This option was granted on June 28, 2022. The shares underlying the Stock Option are scheduled to vest quarterly over four years with the first installment scheduled to vest on August 20, 2022. |
| 9 | Derivative | Stock Option (right to buy) | 2025-02-20 | M | D | 3,172 | $0.00 | 6,343 | D | $7.10 · — to 2033-07-23 | 3,172 Class A Common Stock | (F2) The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F7) This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a two-year period from the vesting start date. |